Rachel Snider, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 102 Coral Dr, Wrightsville Beach, NC 28480 Phone: 910-742-7177 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
Acrongenomics, Inc. are pleased to announce that they have continued their support to Molecular Vision, an emerging developer of quantitative point-of-care (POC) diagnostic devices, by participating in its 2 million GBP funding round. Imperial Innovations Group plc (AIM: IVO, 'Imperial Innovations'), a leading technology commercialisation and investment company, led the £2 million funding round by committing £1.5 million.
GenVec, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade(TM) for the treatment of pancreatic cancer.
British couples considering going abroad for in-vitro fertilisation (IVF) and other types of fertility treatment have been warned against the practice.
A team led by a University of Maryland School of Medicine (UM SOM) researcher, working as a grantee from the National Institutes of Health (NIH), has identified a number of existing drugs that could be "repurposed" to fight outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV).
› Verified 7 days ago